• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

症状前亨廷顿舞蹈病的定量神经病理学变化

Quantitative neuropathological changes in presymptomatic Huntington's disease.

作者信息

Gómez-Tortosa E, MacDonald M E, Friend J C, Taylor S A, Weiler L J, Cupples L A, Srinidhi J, Gusella J F, Bird E D, Vonsattel J P, Myers R H

机构信息

Department of Neurology, Massachusetts General Hospital, Boston, USA.

出版信息

Ann Neurol. 2001 Jan;49(1):29-34.

PMID:11198293
Abstract

Morphometric studies of the tail of the caudate nucleus, the site where the pathology is first seen, were performed on 16 brain specimens collected from individuals at risk for inheriting Huntington's disease (HD). Medical records and information obtained from immediate family members indicated that all had died without symptoms of HD. Six individuals had 37 or more CAG repeats and were designated HD gene carriers, whereas 10 were determined to be non-carriers. Cell counts of the tail of the caudate nucleus revealed an increased density of oligodendrocytes among the presymptomatic HD gene carriers (mean cells/field: carriers = 40.0, noncarrier = 21.3; age, sex, repeated measure adjusted F[126] = 11.7, p = 0.0008). No statistically significant differences were found between HD carriers and noncarriers in the density of neurons (carriers = 16.9, noncarriers = 15.5), astrocytes (carriers = 27.8, noncarriers = 21.3) or microglial cells (carriers = 7.9, noncarriers = 5.6). Ubiquitin immunostaining performed in 3 gene carriers revealed intranuclear inclusions in all 3 cases, including 1, with 37 repeats, who died 3 decades before the expected age for onset of the clinical syndrome. Normal densities of other cell types and careful macroscopic examination suggest that the increase in oligodendroglial density is not a consequence of atrophy and may instead reflect a developmental effect of the HD gene.

摘要

对16份从有遗传亨廷顿舞蹈症(HD)风险的个体采集的脑标本进行了尾状核尾部的形态测量研究,该部位是最早出现病变的地方。从医疗记录和直系家庭成员处获得的信息表明,所有个体去世时均无HD症状。6名个体有37个或更多的CAG重复序列,被指定为HD基因携带者,而10名个体被确定为非携带者。尾状核尾部的细胞计数显示,症状前HD基因携带者中少突胶质细胞密度增加(平均细胞数/视野:携带者 = 40.0,非携带者 = 21.3;年龄、性别、重复测量校正F[1,26] = 11.7,p = 0.0008)。HD携带者和非携带者在神经元密度(携带者 = 16.9,非携带者 = 15.5)、星形胶质细胞密度(携带者 = 27.8,非携带者 = 21.3)或小胶质细胞密度(携带者 = 7.9,非携带者 = 5.6)方面未发现统计学上的显著差异。对3名基因携带者进行的泛素免疫染色显示,所有3例均有核内包涵体,其中1例有37个重复序列,在临床综合征预期发病年龄前30年去世。其他细胞类型的正常密度以及仔细的大体检查表明,少突胶质细胞密度增加不是萎缩的结果,而可能反映了HD基因的发育效应。

相似文献

1
Quantitative neuropathological changes in presymptomatic Huntington's disease.症状前亨廷顿舞蹈病的定量神经病理学变化
Ann Neurol. 2001 Jan;49(1):29-34.
2
Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus.亨廷顿病尾状核中神经元密度降低,少突胶质细胞密度增加。
J Neuropathol Exp Neurol. 1991 Nov;50(6):729-42. doi: 10.1097/00005072-199111000-00005.
3
Huntington's disease: the relationship between clinical signs, CAG repeats and the atrophy of the caudate nucleus in CT scans.
Sb Lek. 1999;100(1):39-44.
4
Genetic load determines atrophy in hand cortico-striatal pathways in presymptomatic Huntington's disease.遗传负荷决定了亨廷顿病前症状期手部皮质纹状体通路的萎缩。
Hum Brain Mapp. 2018 Oct;39(10):3871-3883. doi: 10.1002/hbm.24217. Epub 2018 May 24.
5
Clinicopathological differences between the motor onset and psychiatric onset of Huntington's disease, focusing on the nucleus accumbens.亨廷顿病运动起病和精神起病的临床病理差异,重点关注伏隔核。
Neuropathology. 2019 Oct;39(5):331-341. doi: 10.1111/neup.12578. Epub 2019 Jul 2.
6
White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.临床前期和早期亨廷顿舞蹈症患者的白质完整性与尾状核萎缩及疾病进展相关。
Cortex. 2014 Mar;52:98-112. doi: 10.1016/j.cortex.2013.11.009. Epub 2013 Dec 6.
7
Neuropathological classification of Huntington's disease.亨廷顿舞蹈症的神经病理学分类
J Neuropathol Exp Neurol. 1985 Nov;44(6):559-77. doi: 10.1097/00005072-198511000-00003.
8
Decreased diffusivity in the caudate nucleus of presymptomatic huntington disease gene carriers: which explanation?亨廷顿病基因携带者纹状体扩散率降低:何种解释?
AJNR Am J Neuroradiol. 2010 Apr;31(4):706-10. doi: 10.3174/ajnr.A1891. Epub 2009 Nov 26.
9
Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease.亨廷顿舞蹈病症状前期和症状期的尾状核萎缩率。
Mov Disord. 2000 May;15(3):552-60. doi: 10.1002/1531-8257(200005)15:3<552::AID-MDS1020>3.0.CO;2-P.
10
[A case report of late-onset Huntington disease without family history and caudate atrophy who has diagnosed clinicopathologically and genetically].
No To Shinkei. 1996 Oct;48(10):949-53.

引用本文的文献

1
Mapping iron content and white matter integrity in the anterior thalamic radiations across Huntington's disease stages.绘制亨廷顿舞蹈症各阶段丘脑前辐射中铁含量与白质完整性的图谱。
Neuroimage Clin. 2025 Aug 14;48:103866. doi: 10.1016/j.nicl.2025.103866.
2
Frequency and neuropathology of HTT repeat expansions in FTD/ALS: co-existence rather than causation.额颞叶痴呆/肌萎缩侧索硬化中亨廷顿蛋白(HTT)重复序列扩增的频率及神经病理学:共存而非因果关系。
J Neurol. 2024 Dec 12;272(1):58. doi: 10.1007/s00415-024-12822-2.
3
Small striatal huntingtin inclusions in patients with motor neuron disease with reduced penetrance and intermediate HTT gene expansions.
运动神经元病患者携带小型纹状体亨廷顿蛋白包涵体,其外显率降低,HTT 基因扩增程度中等。
Hum Mol Genet. 2024 Nov 8;33(22):1966-1974. doi: 10.1093/hmg/ddae137.
4
Postmortem neuropathology in early Huntington disease.早发性亨廷顿病的死后神经病理学。
J Neuropathol Exp Neurol. 2024 Apr 19;83(5):294-306. doi: 10.1093/jnen/nlae022.
5
Nebulization of low-dose aspirin ameliorates Huntington's pathology in N171-82Q transgenic mice.低剂量阿司匹林雾化吸入可改善N171-82Q转基因小鼠的亨廷顿氏病理症状。
NeuroImmune Pharm Ther. 2024 Feb 9;3(1):47-59. doi: 10.1515/nipt-2023-0026. eCollection 2024 Mar.
6
Progressive alterations in white matter microstructure across the timecourse of Huntington's disease.进行性改变白质微结构在亨廷顿病的时间过程中。
Brain Behav. 2023 Apr;13(4):e2940. doi: 10.1002/brb3.2940. Epub 2023 Mar 14.
7
Huntington disease oligodendrocyte maturation deficits revealed by single-nucleus RNAseq are rescued by thiamine-biotin supplementation.亨廷顿病少突胶质细胞成熟缺陷通过单细胞 RNAseq 揭示,经硫胺素-生物素补充可得到挽救。
Nat Commun. 2022 Dec 21;13(1):7791. doi: 10.1038/s41467-022-35388-x.
8
Post-mortem 7T MR imaging and neuropathology in middle stage juvenile-onset Huntington disease: A case report.青少年型亨廷顿病中期的尸检7T磁共振成像与神经病理学:一例报告
Neuropathol Appl Neurobiol. 2023 Feb;49(1):e12858. doi: 10.1111/nan.12858. Epub 2022 Nov 13.
9
The distribution and density of Huntingtin inclusions across the Huntington disease neocortex: regional correlations with Huntingtin repeat expansion independent of pathologic grade.亨廷顿病新皮质中亨廷顿蛋白包涵体的分布和密度:与病理分级无关的亨廷顿重复扩展的区域相关性。
Acta Neuropathol Commun. 2022 Apr 19;10(1):55. doi: 10.1186/s40478-022-01364-1.
10
Mutation-related magnetization-transfer, not axon density, drives white matter differences in premanifest Huntington disease: Evidence from in vivo ultra-strong gradient MRI.基因突变相关的磁化传递,而非轴突密度,驱动了无症状亨廷顿病的白质差异:来自活体超强梯度 MRI 的证据。
Hum Brain Mapp. 2022 Aug 1;43(11):3439-3460. doi: 10.1002/hbm.25859. Epub 2022 Apr 9.